1.
Bonifaz
A, Teresa Barrón y Juan Collazo-Jaloma. Zigomicosis. Mucormicosis cutánea en
paciente con leucemia. Actas Dermosifiliogr 2002; 93(8):514-7.
2.
Gomes
M Z. R., Lewis R E. , Kontoyiannis D P. Mucormycosis Caused by Unusual
Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species. Clin Microbiol Rev
2011; 24(2): 411–445.
3.
Bonifaz
A, Macias B, Paredes-Farrera F, Arias P, Ponce RM, Araiza J., Palatal
Zygomicosis: experience of 21 cases. Oral Diseases; 2008; 14:94-100.
4.
Larone
D.H. Medically Important Fungi. A guide
to identification 4th ed. Washington DC: ASM Press; 2002. P.163-177.
5.
Bonifaz
A; Vázquez-González D; Araiza J, Hernández MA, González F, Chavolla R, et al. Mucormycosis in the General Hospital of
Mexico. Experience of 158 cases. Disponible en:
http://www.zygomycota.eu/Meetings/2013/ZygoAbstractBook.pdf.
6.
Brown
J. Zygomicosis: an emerging fungal infection. Am J Health Syst Pharm 2005; 1562:2593-2596.
7.
Cruz
B A,Pérez
PS,Pérez ECy Rovirosa SV. Mucormicosis rinoorbitaria nosocomial
causada porRhizopus oryzae en un lactante desnutrido. Bol Med Hosp Infan
Mex 2001; 58 (1), 35-47.
8.
Zamora-de
la Cruz D, Díaz-Salazar XM, Aguilera JA. Mucormicosis en un paciente con
aplasia medular. Reporte de un caso Mucormycosis in a medullar aplasia patient.
Case report. Revista Mexicana de Oftalmología 2013;87(3):165-170.
9.
Parimalam K,
Zohra BC,
Thirumaran P,and Manoharan
K. Rhino Cerebral Mucormycosis in Systemic Lupus Erythematosus. Indian J
Dermatol 2013;58(2): 158.
10.
Llorentea
A, Perez-Valerob I, García E, Heras I,
Fraile V, García P et al. Mortality risk factors in patients with zygomycosis:
a retrospective and multicentre study of 25 cases. Enferm Infecc Microbiol Clin
2011;29(4):263–268.
11.
Darrisaw
L, Hanson G, Vesole DHand Kehl SC. Cunninghamellainfection post
bone marrow transplant: case report and review of the literature. Macmillan
Publishers Ltd 2000; vol 25 No 11,
p.1213-1216.
12.
Rajiv CM, Joy S M, Ashbee RH, Mathews MS. Mycological profile of fungal sinusitis: An
audit of specimens over a 7-year period in a tertiary care hospital in Tamil
Nadu. . Indian J Pathol Microbiol 2008; 51(4): 493-6.
13.
Garey
KW, Pharm.D., Pendland SL, Huynh
VT, Bunch TH, Jensen GM, et al. CunningTEhamella
bertholletiae Infection in a Bone Marrow Transplant Patient: Amphotericin Lung
Penetration, MIC Determinations, and Review of the Literature. Pharmacotherapy
2001;(7):72-78.
14.
Roden
MM, Zaoutis TE, Buchanan WL, Knudsen TA,
Sarkisovan TA, Schaufele RL y al. Epidemiology
and Outcome of Zygomycosis: A Review of 929 Reported Cases. Clin Infect Dis. 2005;41(5):634-653.
15.
Ng.
T.C. Tony, Colin K. Campbell, Rothera M,
Houghton J. B, Hughes D. Successful Treatmentof SinusitisCaused by
Cunninghamellabertholletiae. Clin Infect Dis.1994; 19(2):313-316.
16. Pastor
FJ, Ruíz-Cendoya M, Pujol I, Mayayo E, Sutton DA and Guarro J. In Vitro and In
Vivo Antifungal Susceptibilities of the Mucoralean Fungus Cunninghamella. Antimicrob
Agents Chemother 2010;
54(11): 4550–4555.
17.
Ribes
JA,Vanover-Sams
CL,andBaker
DJ. Zygomycetes in Human Disease. . Clin Microbiol Rev. 2000; 13(2): 236–301.
18.
Calabria
O B, Acosta A. N, Gallegos L y Vargas M H. Mucormicosis cutánea en un recién
nacido pretérmino: A propósito de un caso.. KasmeraMaracaibo 2005;
2(33)20-26.
19.
Pimentel
JD, Dreyer G and Lum G D. Peritonitis due to Cunninghamella bertholletiae in a
patient undergoing continuous ambulatory peritoneal dialysis. J Med Microbiol 2006; 1(55), 115–118.
